231 related articles for article (PubMed ID: 8183551)
21. Characterization of the isoforms of MOVO zinc finger protein, a mouse homologue of Drosophila Ovo, as transcription factors.
Unezaki S; Nishizawa M; Okuda-Ashitaka E; Masu Y; Mukai M; Kobayashi S; Sawamoto K; Okano H; Ito S
Gene; 2004 Jul; 336(1):47-58. PubMed ID: 15225875
[TBL] [Abstract][Full Text] [Related]
22. The Evi-1 zinc finger myeloid transforming gene is normally expressed in the kidney and in developing oocytes.
Morishita K; Parganas E; Parham DM; Matsugi T; Ihle JN
Oncogene; 1990 Sep; 5(9):1419-23. PubMed ID: 1699199
[TBL] [Abstract][Full Text] [Related]
23. Analysis of zinc fingers optimized via phage display: evaluating the utility of a recognition code.
Wolfe SA; Greisman HA; Ramm EI; Pabo CO
J Mol Biol; 1999 Feb; 285(5):1917-34. PubMed ID: 9925775
[TBL] [Abstract][Full Text] [Related]
24. Identification of candidate target genes for EVI-1, a zinc finger oncoprotein, using a novel selection strategy.
Kim JH; Hui P; Yue D; Aycock J; Leclerc C; Bjoring AR; Perkins AS
Oncogene; 1998 Sep; 17(12):1527-38. PubMed ID: 9794230
[TBL] [Abstract][Full Text] [Related]
25. A folding transition and novel zinc finger accessory domain in the transcription factor ADR1.
Bowers PM; Schaufler LE; Klevit RE
Nat Struct Biol; 1999 May; 6(5):478-85. PubMed ID: 10331877
[TBL] [Abstract][Full Text] [Related]
26. Evi-1 ZF1 DNA binding activity and a second distinct transcriptional repressor region are both required for optimal transformation of Rat1 fibroblasts.
Kilbey A; Bartholomew C
Oncogene; 1998 Apr; 16(17):2287-91. PubMed ID: 9619838
[TBL] [Abstract][Full Text] [Related]
27. The Evi-1 proto-oncogene encodes a transcriptional repressor activity associated with transformation.
Bartholomew C; Kilbey A; Clark AM; Walker M
Oncogene; 1997 Feb; 14(5):569-77. PubMed ID: 9053855
[TBL] [Abstract][Full Text] [Related]
28. Unique expression of the human Evi-1 gene in an endometrial carcinoma cell line: sequence of cDNAs and structure of alternatively spliced transcripts.
Morishita K; Parganas E; Douglass EC; Ihle JN
Oncogene; 1990 Jul; 5(7):963-71. PubMed ID: 2115646
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the DNA binding activity of the ZFY zinc finger domain.
Grants J; Flanagan E; Yee A; Romaniuk PJ
Biochemistry; 2010 Feb; 49(4):679-86. PubMed ID: 20028140
[TBL] [Abstract][Full Text] [Related]
30. Abnormal expression of Evi-1 gene in human leukemias.
Ogawa S; Mitani K; Kurokawa M; Matsuo Y; Minowada J; Inazawa J; Kamada N; Tsubota T; Yazaki Y; Hirai H
Hum Cell; 1996 Dec; 9(4):323-32. PubMed ID: 9183665
[TBL] [Abstract][Full Text] [Related]
31. Retroviral insertions 90 kilobases proximal to the Evi-1 myeloid transforming gene activate transcription from the normal promoter.
Bartholomew C; Ihle JN
Mol Cell Biol; 1991 Apr; 11(4):1820-8. PubMed ID: 1848663
[TBL] [Abstract][Full Text] [Related]
32. Finger-loops, oncogenes, and metals. Claude Passmore Brown memorial lecture.
Sunderman FW; Barber AM
Ann Clin Lab Sci; 1988; 18(4):267-88. PubMed ID: 2841900
[TBL] [Abstract][Full Text] [Related]
33. Evi-1, a murine zinc finger proto-oncogene, encodes a sequence-specific DNA-binding protein.
Perkins AS; Fishel R; Jenkins NA; Copeland NG
Mol Cell Biol; 1991 May; 11(5):2665-74. PubMed ID: 2017172
[TBL] [Abstract][Full Text] [Related]
34. Serine at position 2 in the DNA recognition helix of a Cys2-His2 zinc finger peptide is not, in general, responsible for base recognition.
Kim CA; Berg JM
J Mol Biol; 1995 Sep; 252(1):1-5. PubMed ID: 7666422
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the DNA-binding properties of the myeloid zinc finger protein MZF1: two independent DNA-binding domains recognize two DNA consensus sequences with a common G-rich core.
Morris JF; Hromas R; Rauscher FJ
Mol Cell Biol; 1994 Mar; 14(3):1786-95. PubMed ID: 8114711
[TBL] [Abstract][Full Text] [Related]
36. Evi-1 raises AP-1 activity and stimulates c-fos promoter transactivation with dependence on the second zinc finger domain.
Tanaka T; Nishida J; Mitani K; Ogawa S; Yazaki Y; Hirai H
J Biol Chem; 1994 Sep; 269(39):24020-6. PubMed ID: 7929053
[TBL] [Abstract][Full Text] [Related]
37. Loss of erythropoietin responsiveness in erythroid progenitors due to expression of the Evi-1 myeloid-transforming gene.
Kreider BL; Orkin SH; Ihle JN
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6454-8. PubMed ID: 8341654
[TBL] [Abstract][Full Text] [Related]
38. Induction of two alternatively spliced evi-1 proto-oncogene transcripts by cAMP in kidney cells.
Bartholomew C; Clark AM
Oncogene; 1994 Mar; 9(3):939-42. PubMed ID: 8108138
[TBL] [Abstract][Full Text] [Related]
39. Exploring the DNA-binding specificities of zinc fingers with DNA microarrays.
Bulyk ML; Huang X; Choo Y; Church GM
Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7158-63. PubMed ID: 11404456
[TBL] [Abstract][Full Text] [Related]
40. Retroviral insertions in the CB-1/Fim-3 common site of integration activate expression of the Evi-1 gene.
Bartholomew C; Morishita K; Askew D; Buchberg A; Jenkins NA; Copeland NG; Ihle JN
Oncogene; 1989 May; 4(5):529-34. PubMed ID: 2542863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
